UNSPSC 51294509: Metioxate

This classification denotes an antibiotic with the molecular formula C22H27N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 00V69U1QC7 chemically known as 2-(4-methylpiperidino)ethyl 6-ethyl-2,3,6,9-tetrahydro-3-methyl-2,9-dioxothiazolo(5,4-f)quinoline-8-carboxylate but generally known as metioxate, which bears US NIH Compound Identifier 3047729. European Medicines Agency schedules Metioxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08890MIG.

UNSPSC 51294509 Metioxate (Commodity) covers pharmaceutical preparations and related medical products that state and local health agencies procure to support public health initiatives, though the recent activity under this code reflects a mismatch between the code's nominal scope and the work actually being solicited. Seminole County, Florida released a competitive IFB in June 2026 for naloxone and drug deactivation systems—opioid-response and harm-reduction products rather than metioxate—indicating that state and local procurement offices may tag acquisitions of emergency pharmaceutical supplies and medical countermeasures to this code despite the nominal product line. The buy reflects typical county health department procurement: volume quantities with defined delivery schedules, fixed-fee pricing structures, and standard compliance requirements including drug-free workplace certification, E-Verify authorization, and insurance coverage (workers' compensation, general liability, professional liability). Contract terms span an initial two-year period with optional renewal, suggesting sustained demand for ongoing supply.

The source shows limited recent activity under the code; only the Seminole County opportunity appears in the dataset. Seminole County, a mid-sized Florida county health authority, solicited 1,900 units of naloxone and 800 drug deactivation systems annually through IFB 60459723LAS with a response deadline of July 26, 2023, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement mentions potential FEMA funding, which introduces federal compliance overlay (Clean Air Act, Federal Water Pollution Control Act) and audit exposure. The source does not support characterization of broader state-local activity, geographic concentration, or other jurisdictional buyers under this code; businesses should verify whether this code is actively used across other state and local health procurement offices or whether the Seminole County opportunity represents an isolated tagging decision.